Clinical benefit of early treatment with bone‐modifying agents for preventing skeletal‐related events in patients with genitourinary cancer with bone metastasis: A multi‐institutional retrospective study-Reference-Cited by-同舟云学术

Clinical benefit of early treatment with bone‐modifying agents for preventing skeletal‐related events in patients with genitourinary cancer with bone metastasis: A multi‐institutional retrospective study

Published:2019-03-18 Issue:6 Volume:26 Page:630-637
ISSN:0919-8172
Container-title:International Journal of Urology
language:en
Short-container-title:Int. J. Urol.

Author:

Owari Takuya¹,Miyake Makito¹,Nakai Yasushi¹,Hori Shunta¹,Tomizawa Mitsuru¹,Ichikawa Kazuki¹,Shimizu Takuto¹,Iida Kota²³,Samma Shoji²⁴,Iemura Yusuke²⁴,Momose Hitoshi²⁵,Omori Chihiro²⁵,Otani Takeshi²⁶,Kuwada Masaomi²⁶,Hirao Shuya²⁷,Oyama Nobuo²⁸,Nakagawa Yoshinori²³,Hayashi Yoshiki²⁹,Tanaka Nobumichi¹,Fujimoto Kiyohide¹

Affiliation:

1. Department of Urology Nara Medical University Kashihara Nara Japan

2. Nara Urological Research and Treatment Group Nara Nara Japan

3. Department of Urology Yamatotakada Municipal Hospital Yamatotakada Nara Japan

4. Department of Urology Nara Prefecture General Medical Center Nara Nara Japan

5. Department of Urology Hoshigaoka Medical Center Hirakata Osaka Japan

6. Department of Urology Matsuzaka General Hospital Matsuzaka Mie Japan

7. Department of Urology Hirao Hospital Kashihara Nara Japan

8. Department of Urology Seiwa Medical Center Ikoma Nara Japan

9. Department of Urology Tane General Hospital Osaka Osaka Japan

Publisher

Wiley